Clinical trials
Intellectual Disability trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Connecta Therapeutics, S.L. | 3 |
| University of Malaga | 2 |
| Clinica Universidad de Navarra, Universidad de Navarra | 1 |
| Fundación Hospitalarias Betanzos | 1 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 1 |
| Parc de Salut Mar | 1 |
| Universidad Católica San Antonio de Murcia | 1 |
| Universidad Pontificia Comillas | 1 |
| Universidade da Coruña | 1 |
| University of Extremadura | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intellectual Disability | 15 |
| Fragile X Syndrome | 4 |
| Central Nervous System Diseases | 3 |
| Congenital Abnormalities | 3 |
| Genetic Diseases, X-Linked | 3 |
| Neurobehavioral Manifestations | 3 |
| Neurodevelopmental Disorders | 3 |
| Rare Diseases | 3 |
| Down Syndrome | 2 |
| Alzheimer Disease | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.